138 related articles for article (PubMed ID: 7866337)
1. Plasma protein C and antithrombin III in patients with acute leukemia.
Cucuianu A; Brudaşcă I; Colhon D; Paţiu M; Basarab C; Cucuianu M
Rom J Intern Med; 1994; 32(3):209-14. PubMed ID: 7866337
[TBL] [Abstract][Full Text] [Related]
2. Clinical studies on plasma protein C. Correlation with serum cholinesterase.
Cucuianu M; Brudasca I; Trif I; Stancu A
Nouv Rev Fr Hematol (1978); 1993; 35(5):481-6. PubMed ID: 8295822
[TBL] [Abstract][Full Text] [Related]
3. Serum cholesterol and apoprotein B levels and serum cholinesterase activity in selected hematologic malignancies.
Cucuianu A; Malide D; Petrov L; Patiu M; Vlaicu S; Cucuianu M
Rom J Intern Med; 1992; 30(4):261-8. PubMed ID: 1299417
[TBL] [Abstract][Full Text] [Related]
4. Roles of protein C, protein S, and antithrombin III in acute leukemia.
Dixit A; Kannan M; Mahapatra M; Choudhry VP; Saxena R
Am J Hematol; 2006 Mar; 81(3):171-4. PubMed ID: 16493609
[TBL] [Abstract][Full Text] [Related]
5. Protein C, protein S and antithrombin III levels in the course of bone marrow and subsequent liver transplantation due to veno-occlusive disease.
Salat C; Holler E; Göhring P; Poley S; Kolb HJ; Pihusch R; Reinhardt B; Krämling HJ; Haller M; Hiller E
Eur J Med Res; 1996 Nov; 1(12):571-4. PubMed ID: 9438165
[TBL] [Abstract][Full Text] [Related]
6. Resistance to activated protein C and low levels of free protein S in Greek patients with inflammatory bowel disease.
Koutroubakis IE; Sfiridaki A; Mouzas IA; Maladaki A; Kapsoritakis A; Roussomoustakaki M; Kouroumalis EA; Manousos ON
Am J Gastroenterol; 2000 Jan; 95(1):190-4. PubMed ID: 10638581
[TBL] [Abstract][Full Text] [Related]
7. Functional and antigenic antithrombin III in angina pectoris and acute myocardial infarction patients.
Vonica A; Văgăonescu T; Cristea A; Stăncioiu N
Med Interne; 1990; 28(4):311-7. PubMed ID: 2100876
[TBL] [Abstract][Full Text] [Related]
8. Increased plasma factor VIII:c activity in patients with unstable angina pectoris.
Olinic D; Brudaşcă I; Colhon D; Stoia M; Cucuianu M
Rom J Intern Med; 1996; 34(1-2):65-71. PubMed ID: 8908632
[TBL] [Abstract][Full Text] [Related]
9. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
10. [Coagulation inhibitors in patients with neoplasms].
Páramo JA; Cuesta B; Hernández M; Fernández J; Paloma MJ; Rifón J; Rocha E
Med Clin (Barc); 1989 Feb; 92(5):164-6. PubMed ID: 2524631
[TBL] [Abstract][Full Text] [Related]
11. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
[TBL] [Abstract][Full Text] [Related]
12. Protein C and antithrombin III in children with acute leukemia.
Atlihan F; Karakaş Z; Batun S
Turk J Pediatr; 1993; 35(1):45-51. PubMed ID: 8236517
[TBL] [Abstract][Full Text] [Related]
13. Daily modifications of plasma fibrinogen platelets aggregation, Howell's time, PTT, TT, and antithrombin II in normal subjects and in patients with vascular disease.
Petralito A; Mangiafico RA; Gibiino S; Cuffari MA; Miano MF; Fiore CE
Chronobiologia; 1982; 9(2):195-201. PubMed ID: 7117042
[TBL] [Abstract][Full Text] [Related]
14. Effects of recombinant human erythropoietin on physiological inhibitors of coagulation in children on continuous ambulatory peritoneal dialysis.
Kisaarslan FA; Gündüz Z; Düsünsel R; Poyrazoglu HM; Saraymen R; Elmas B
Adv Perit Dial; 1999; 15():273-7. PubMed ID: 10682117
[TBL] [Abstract][Full Text] [Related]
15. [Antithrombin III control in patients with long-term anticoagulant therapy].
Hönig JF; Merten HA; Korth O; Halling F; Köstering H
Dtsch Z Mund Kiefer Gesichtschir; 1991; 15(5):330-3. PubMed ID: 1840095
[TBL] [Abstract][Full Text] [Related]
16. Effects of dose-reduced Medac L-asparaginase on coagulation in trial ALL-BFM 2000.
Attarbaschi A; Mann G; Kronberger M; Witt V; Gadner H; Dworzak M
Klin Padiatr; 2003; 215(6):321-6. PubMed ID: 14677096
[TBL] [Abstract][Full Text] [Related]
17. Analysis of coagulation parameters in the early period after kidney transplantation.
Pawlicki J; Cierpka L; Król R; Ziaja J
Transplant Proc; 2007 Nov; 39(9):2754-5. PubMed ID: 18021978
[TBL] [Abstract][Full Text] [Related]
18. Alterations in natural anticoagulant levels during allogeneic bone marrow transplantation: a prospective study in 27 patients.
Leblond V; Salehian BD; Borel C; Mapakou CP; Dombret H; Sutton L; Binet JL; Ankri A
Bone Marrow Transplant; 1993 Apr; 11(4):299-305. PubMed ID: 8485478
[TBL] [Abstract][Full Text] [Related]
19. [Changes in coagulation inhibitors (AT III, protein C, protein S) in patients with liver cirrhosis].
Kobayashi I; Kurihara A; Hamaoka S; Amemiya N; Endo T; Okuyama K
Rinsho Byori; 1989 Apr; Spec No 81():93-7. PubMed ID: 2526888
[No Abstract] [Full Text] [Related]
20. Plasma protein S-antigen (PS:Ag) in selected disease states.
Brudaşca I; Cucuianu M; Stancu A; Colhon DM
Rom J Intern Med; 1994; 32(1):29-35. PubMed ID: 8081308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
